Latest news
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 - Business WireBusiness Wire · Wed, 05 Aug 2026 12:00:00 GMTEnveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMT